Search research articles

关于 JoVE

概览领导团队博客 JoVE 帮助中心

作者

出版流程编辑委员会范围与政策同行评审常见问题投稿

图书馆员

用户评价订阅访问资源图书馆顾问委员会常见问题

研究

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments 存档

教育

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual 教师资源中心教师网站

使用条款与条件

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序

Same author

Subretinal Tissue Plasminogen Activator Injection Using a Nanovitreoretinal Device for Massive Submacular Hemorrhage: A Retrospective Case Series.

Korean journal of ophthalmology : KJO·2026

Same author

Effect of Korean red ginseng on deep capillary plexus parameters in diabetic retinopathy: A prospective, randomized, double-blind clinical trial.

Journal of ginseng research·2026

Same author

Clinical Utility of Ultra-Widefield Swept-Source OCT for Intraocular Tumors: Comparison With Ultrasonography, SD-OCT, and MRI.

American journal of ophthalmology·2026

Same author

Age-Related Patterns of Pseudomelanomas in Patients Referred for Suspected Uveal Melanoma at a Tertiary Ocular Oncology Center.

Retina (Philadelphia, Pa.)·2026

Same author

cP1P Maintains Long-Term Pluripotency in Human Pluripotent Stem Cells.

International journal of stem cells·2026

Same author

Recombinant live biotherapeutics and synthetic biology: Recent advancement and perspective.

Progress in molecular biology and translational science·2026

Search research articles

相关实验视频

Updated: Jun 1, 2025

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

在治疗眼睛疾病的CRISPR/Cas9系统方面,近期取得的进展.

D A Ayush Gowda¹, Girish Birappa¹, Sripriya Rajkumar¹

¹Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, South Korea.

Progress in molecular biology and translational science

|January 17, 2025

概括

通过纠正基因突变,CRISPR/Cas9基因编辑系统显示出治疗眼部疾病的前景. 这项技术正在推动眼睛疾病的新疗法开发.

关键词:

这是一种失明,失明.这就是CRISPR/Cas9的作用.临床试验中的临床试验.眼睛疾病眼睛疾病基因编辑基因编辑核酶是一种核酶.病理学病理学病理学视网膜退化视网膜退化单导向RNA是指导性RNA的一个单导向RNA.治疗方法治疗方法视力受损视力受损

更多相关视频

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Microinjection of Corn Planthopper, Peregrinus maidis, Embryos for CRISPR/Cas9 Genome Editing

Microinjection of Corn Planthopper, Peregrinus maidis, Embryos for CRISPR/Cas9 Genome Editing

Published on: March 26, 2021

相关实验视频

Last Updated: Jun 1, 2025

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Microinjection of Corn Planthopper, Peregrinus maidis, Embryos for CRISPR/Cas9 Genome Editing

Microinjection of Corn Planthopper, Peregrinus maidis, Embryos for CRISPR/Cas9 Genome Editing

Published on: March 26, 2021

科学领域:

眼科医生眼科眼科
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

眼部疾病由于遗传和环境因素而表现出各种症状.
眼睛的独特结构支持先进的基因编辑疗法.
基因组编辑为各种疾病提供了潜在的治疗方法,包括眼睛疾病.

研究的目的:

探索CRISPR/Cas9技术在眼科中的应用.
讨论使用CRISPR/Cas9.9生成眼病模型.
审查CRISPR/Cas9对眼睛病理的当前和未来治疗用途.

主要方法:

在眼科研究中利用CRISPR/Cas9系统进行基因编辑.
在哺乳动物细胞系和体内生成眼病模型.
研究患者衍生细胞中突变的纠正.

主要成果:

在哺乳动物眼睛发育和疾病模型中,CRISPR/Cas9使基因修饰成为可能.
成功纠正患者衍生眼细胞中的有害突变.
开发各种眼病模型进行进一步研究.

结论:

克里斯普尔/卡斯9技术是研究和潜在治疗眼部疾病的强大工具.
需要进一步的研究来克服挑战,并充分实现治疗潜力.
这种基因编辑系统对眼科的未来具有重大前景.